The American Journal of Surgery
Volume 194, Issue 4, Supplement , Pages S28-S32 , October 2007

Phospholipase A2 in acute pancreatitis: review

  • Timo J. Nevalainen, M.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +358-2-3337500; fax: +358-2-3337459.

References 

  1. Schmidt H, Creutzfeldt W. The possible role of phospholipase A in the pathogenesis of acute pancretitis. Scand J Gastroenterol. 1969;4:39–48
  2. Creutzfeldt W, Schmidt H. Aetiology and pathogenesis of pancreatitis (current concepts). Scand J Gastroenterol Suppl. 1970;6:47–62
  3. Nevalainen TJ. The role of phospholipase A2 in acute pancreatitis (Review). Scand J Gastroenterol. 1980;15:641–650
  4. Nevalainen TJ. Phospholipase A2 in acute pancreatitis (Review). Scand J Gastroenterol. 1988;23:897–904
  5. Nevalainen TJ, Grönroos JM. Phospholipase A2 in acute pancreatitis. In:  Glaser KB,  Vadas P editor. Phospholipase A2 in Clinical Inflammation. (Molecular Approaches to Pathophysiology). New York, NY: CRC Press; 1995;p. 149–179
  6. Six DA, Dennis EA. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim Biophys Acta. 2000;1488:1–19
  7. Rouault M, Bollinger JG, Lazdunski M, et al. Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. Biochemistry. 2003;42:11494–11503
  8. Eskola JU, Nevalainen TJ, Aho HJ. Purification and characterization of human pancreatic phospholipase A2. Clin Chem. 1983;29:1771–1776
  9. Nevalainen TJ, Haapanen TJ. Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation. 1993;17:453–464
  10. Seilhamer JJ, Randall TL, Yamanaka M, et al. Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA. 1986;5:519–527
  11. Seilhamer JJ, Pruzanski W, Vadas P, et al. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem. 1989;264:5335–5338
  12. Kramer RM, Hession C, Johansen B, et al. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem. 1989;264:5768–5775
  13. Kallajoki M, Nevalainen TJ. Expression of group II phospholipase A2 in human tissues. Prog Surgery. 1997;24:8–16
  14. Nevalainen TJ, Eerola LI, Rintala E, et al. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim Biophys Acta. 2005;1733:210–223
  15. Martikainen P, Nyman K, Nevalainen TJ. Toxic effects of human pancreatic and snake and bee venom phospholipases A2 on MCF-7 cells in culture. Toxicon. 1993;31:835–843
  16. Kimura W, Secknus R, Fischbach W, et al. Role of phospholipase A2 in pancreatic acinar cell damage and possibilities of inhibition: studies with isolated rat pancreatic acini. Pancreas. 1993;8:70–79
  17. Kahle M, König H, Filler RD. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis. Klin Wochenschr. 1989;67:177–179
  18. Zieve L, Vogel WC. Measurement of lecithinase A in serum and other body fluids. J Lab Clin Med. 1961;57:586–599
  19. Schröder T, Kivilaakso E, Kinnunen PKJ, et al. Serum phospholipase A2 in human acute pancreatitis. Scand J Gastroenterol. 1980;15:633–636
  20. Eskola JU, Nevalainen TJ, Lövgren TN-E. Time-resolved fluoroimmunoassay of human pancreatic phospholipase A2. Clin Chem. 1983;29:1777–1780
  21. Nevalainen TJ, Eskola JU, Aho AJ, et al. Immunoreactive phospholipase A2 in serum in acute pancreatitis and pancreatic cancer. Clin Chem. 1985;31:1116–1120
  22. Büchler M, Malfertheiner P, Schädlich H, et al. Role of phospolipase A2 in human acute pancreatitis. Gastroenterology. 1989;97:1521–1526
  23. Eskola JU, Nevalainen TJ, Kortesuo P. Immunoreactive pancreatic phospholipase A2 and catalytically active phospholipases A2 in serum from patients with acute pancreatitis. Clin Chem. 1988;34:1052–1055
  24. Nevalainen TJ, Kortesuo PT, Rintala E, et al. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem. 1992;38:1824–1829
  25. Nevalainen TJ, Grönroos JM, Kortesuo PT. Pancreatic and synovial type phospholipase A2 in serum samples from patients with severe acute pancreatitis. Gut. 1993;34:1133–1136
  26. Crowl RM, Stoller TJ, Conroy RR, et al. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991;266:2647–2651
  27. Pruzanski W, Wilmore DW, Suffredini A, et al. Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin. Inflammation. 1992;16:561–570
  28. Nevalainen TJ, Haapamäki MM, Grönroos JM. Review (Roles of secretory phospholipases A2 in inflammatory diseases and trauma). Biochim Biophys Acta. 2000;1488:83–90
  29. Rintala E, Pulkki K, Mertsola J, et al. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies. Scand J Infect Dis. 1995;27:39–43
  30. Foulis AK, Murray WR, Galloway D, et al. Endotoxaemia and complement activation in acute pancreatitis in man. Gut. 1982;23:656–661
  31. Laine VJO, Grass DS, Nevalainen TJ. Protection by group II phospholipase A2 against Staphylococcus aureus. J Immunol. 1999;162:7402–7408
  32. Koduri RS, Gronroos JO, Laine VJO, et al. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem. 2002;277:5849–5857
  33. Hack CE, Wolbink GJ, Schalwijk C, et al. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today. 1997;18:11–15
  34. Talvinen KA, Kemppainen EA, Nevalainen TJ. Expression of group II phospholipase A2 in the liver in acute pancreatitis. Scand J Gastroenterol. 2001;36:1217–1221
  35. Nevalainen TJ, Kallajoki M, Pesonen E, et al. Origin of circulating group II phospholipase A2 in hepatocytes in patients with epithelioid hemangioendothelioma of the liver. Lab Invest. 1996;74:585–591
  36. Laine VJO, Grönroos JM, Nevalainen TJ. Serum phospholipase A2 after splenectomy. Eur J Clin Chem Clin Biochem. 1996;34:419–422
  37. Rintala EM, Nevalainen TJ. Synovial-type (group II) phospholipase A2 in serum of febrile patients with haematological malignancy. Eur J Haematol. 1993;50:11–16
  38. Degousee N, Ghomashchi F, Stefanski E, et al. Groups IV, V, and X phospholipases A2 in human neutrophils: role in eicosanoid production and Gram-negative bacterial phospholipid hydrolysis. J Biol Chem. 2002;277:5061–5073
  39. Motoyoshi M, Sugiyama , Atomi Y, et al. In vivo effect of pancreatic phospholipase A2 on the arachidonic acid cascade. Int J Pancreatol. 2001;29:69–76
  40. Hongo H, Takano , Imai A, et al. Pancreatic phospholipase A2 induces bacterial translocation in rats. Immunopharmacol Immunotoxicol. 1999;21:717–726
  41. Grönroos JM, Nevalainen TJ. Increased concentrations of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion. 1992;52:232–236
  42. Holm BA, Keicher L, Liu MY, et al. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol. 1991;71:317–321
  43. Tsukahara Y, Morisaki T, Horita Y, et al. Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis. Ann Surg. 1999;229:385–392
  44. Vadas P, Browning J, Edelson J, et al. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat. 1993;8:1–30
  45. Grass DS, Felkner RH, Chiang M-Y, et al. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest. 1996;97:2233–2241
  46. Kennedy BP, Payette P, Mudgett J, et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem. 1995;270:22378–22385
  47. Mayer JM, Laine VJO, Kolodziej S, et al. Acute pancreatitis in transgenic mice expressing human group IIA phospholipase A2. Pancreas. 2002;25:188–191
  48. Kihara Y, Yoshikawa H, Honda H, et al. Natural disruption of group 2 phospholipase A2 gene protects against choline-deficient ethionine-supplemented diet-induced acute pancreatitis and lung injury. Pancreas. 2005;31:48–53
  49. Scott KF, Graham GG, Bryant KJ. Secreted phospholipase A2 enzymes as therapeutic targets. Expert Opin Ther Targets. 2003;7:427–440
  50. Reid RC. Inhibitors of secretory phospolipase A2 group IIA. Curr Med Chem. 2005;12:3011–3026
  51. Malfertheiner P, Nevalainen T, Uhl W, et al. Diagnostic value of immunoreactive phospholipase A2 in acute pancreatitis. Klin Wochenschr. 1989;67:183–185
  52. Büchler M, Malfertheiner P, Schoetensack C, et al. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis: results of a prospective clinical study. Int J Pancreatol. 1986;1:227–235
  53. Mayer J, Rau B, Grewe M, et al. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas. 1998;17:272–277
  54. Borgström A, Appelros S, Möller CA, et al. Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery. 2001;131:125–128
  55. Mayer JM, Raraty M, Slavin J, et al. Severe acute pancreatitis is related to increased early urinary levels of the activation peptide of pancreatic phospholipase A2. Pancreatology. 2002;2:535–542

PII: S0002-9610(07)00341-8

doi: 10.1016/j.amjsurg.2007.04.004

The American Journal of Surgery
Volume 194, Issue 4, Supplement , Pages S28-S32 , October 2007

Article Tools